NY-based co. closing Syracuse-area lab in July
AP - Thu Apr 17, 10:10AM CDT
CICERO, N.Y. (AP) — An Albany-based pharmaceutical company that's part of a $250 million economic development project in Buffalo is shutting down its Syracuse-area research center, eliminating 45 jobs.
AMRI Realigns Discovery and Development Services to Support Customer Demand
PR Newswire Europe - Wed Apr 16, 8:01AM CDT
AMRI today announced that it will be transitioning Discovery and Development Services (DDS) activities at its Syracuse, N.Y. site to other sites within AMRI and will cease operations in Syracuse by the end of June 2014. The actions taken today are consistent with AMRI's ongoing efforts to consolidate its facility resources to more effectively utilize its discovery and development resource pool and to further reduce its facility cost structure.
Morning Briefing on Top Gainers -- Research on Science Applications Intl., Maxwell Technologies, Albany Molecular Research, and Demandware
PR Newswire - Thu Apr 10, 12:04PM CDT
The US markets saw a positive sentiment on Wednesday, April 09, 2014, with the NASDAQ Composite closing at 4,183.90, up 1.72%, the Dow Jones Industrial Average ending the session at 16,437.18, up 1.11%, and the S&P 500 edging 1.09% higher to finish the trading session at 1,872.18. The session saw a positive impact from Information Technology, Health Care and Materials sectors along with a drag from Utilities and Telecommunication Services sectors. A number of stocks saw large movements, including Science Applications International Corp. (NYSE: SAIC), Maxwell Technologies Inc. (NASDAQ: MXWL), Albany Molecular Research Inc. (NASDAQ: AMRI) and Demandware Inc. (NYSE: DWRE). Free technical research on SAIC, MXWL, AMRI and DWRE can be downloaded upon signing up at:
Financial Results Announcement, Stock Movement, Presentations, and Acquisition - Analyst Notes on Universal Health Services, Tenet, Cynosure, Albany Molecular Research, and Enanta
PR Newswire - Thu Apr 10, 9:49AM CDT
Today, Analysts Review released its analysts' notes regarding Universal Health Services, Inc. (NYSE: UHS), Tenet Healthcare Corp. (NYSE: THC), Cynosure, Inc. (NASDAQ: CYNO), Albany Molecular Research Inc. (NASDAQ: AMRI), and Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Albany Molecular Research (AMRI) Showing Signs Of A Dead Cat Bounce Today
at The Street - Wed Apr 09, 8:59AM CDT
Trade-Ideas LLC identified Albany Molecular Research (AMRI) as a "dead cat bounce" (down big yesterday but up big today) candidate
AMRI Completes Acquisition of Cedarburg Pharmaceuticals, Inc.
PR Newswire Europe - Fri Apr 04, 3:10PM CDT
AMRI today announced that it has completed the previously announced acquisition of Cedarburg Pharmaceuticals, Inc.
Albany Molecular Research Has Returned 52.0% Since SmarTrend Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Apr 04, 9:37AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 2 months, Albany Molecular Research has returned 51.98% as of today's recent price of $17.66.
Insider Trading Alert - AMRI, CHE And LXK Traded By Insiders
at The Street - Thu Apr 03, 10:45AM CDT
Stocks with insider trader activity include AMRI, CHE and LXK
Albany Molecular Research Shares Up 58.9% Since SmarTrend's Buy Recommendation (AMRI)
Comtex SmarTrend(R) - Fri Mar 28, 9:09AM CDT
SmarTrend identified an Uptrend for Albany Molecular Research (NASDAQ:AMRI) on February 12th, 2014 at $11.62. In approximately 1 month, Albany Molecular Research has returned 58.95% as of today's recent price of $18.47.
Facility Investments, Earnings Release Schedules, Definitive Agreements, Patient Enrollments, and Clinical Trial Updates - Analyst Notes on Novo Nordisk, HealthSouth, AMRI, Abiomed, and Geron
PR Newswire - Thu Mar 27, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Novo Nordisk A/S (NYSE: NVO), HEALTHSOUTH Corp. (NYSE: HLS), Albany Molecular Research Inc. (NASDAQ: AMRI), Abiomed Inc. (NASDAQ: ABMD), and Geron Corporation (NASDAQ: GERN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Essex Property Set to Join S&P 500; Cliff Natural Resources, FEI to Join S&P MidCap 400; Fabrinet, Albany Molecular Research to Join S&P SmallCap 600
PR Newswire - Wed Mar 26, 5:10PM CDT
S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600 indices after the close of trading on Tuesday, April 1:
AMRI CEO to Present at the Thirteenth Annual Needham Healthcare Conference
PR Newswire Europe - Wed Mar 26, 7:01AM CDT
Albany Molecular Research Inc. announced today that William S. Marth, President and Chief Executive Officer at AMRI, will present at the Thirteenth Annual Needham Healthcare Conference on Wednesday, April 9, 2014 at 10:00 a.m. ET.
AMRI to Acquire API Manufacturer Cedarburg Pharmaceuticals for $41M
Jeff Engel, The Motley Fool - Motley Fool - Mon Mar 24, 5:30PM CDT
Cedarburg Hauser Pharmaceuticals , the Grafton, WI-based contract developer and manufacturer of active pharmaceutical ingredients (API) for the drug industry, will be acquired for $41 million by Albany Molecular Research, , the two companies ...
Today’s Top Biotech Stories: Albany Molecular Research, Rockwell Medical, and Celgene
Leo Sun, The Motley Fool - Motley Fool - Mon Mar 24, 8:16AM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. Let's take a look at three stocks -- Albany Molecular...
AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
PR Newswire Europe - Mon Mar 24, 6:01AM CDT
- Broadens Contract Development and Manufacturing Capabilities with High Value, Complex API Business -